Found: 58
Select item for more details and to access through your institution.
CANCER THERAPY BY CYCLIN-DEPENDENT KINASE INHIBITORS (CDKIS): BENCH TO BEDSIDE.
- Published in:
- EXCLI Journal, 2024, v. 23, p. 862, doi. 10.17179/excli2024-7076
- By:
- Publication type:
- Article
DETAILED ROLE OF MESENCHYMAL STEM CELL (MSC)- DERIVED EXOSOME THERAPY IN CARDIAC DISEASES.
- Published in:
- EXCLI Journal, 2024, v. 23, p. 401, doi. 10.17179/excli2023-6538
- By:
- Publication type:
- Article
MicroRNAs Targeting Programmed Cell Death Protein 1 (PD-1) Promote Natural Killer Cell Exhaustion in Rheumatoid Arthritis.
- Published in:
- Iranian Journal of Allergy, Asthma & Immunology, 2022, v. 21, n. 6, p. 646, doi. 10.18502/ijaai.v21i6.11524
- By:
- Publication type:
- Article
An updated overview of the application of CAR‐T cell therapy in neurological diseases.
- Published in:
- Biotechnology Progress, 2023, v. 39, n. 5, p. 1, doi. 10.1002/btpr.3356
- By:
- Publication type:
- Article
Antifungal Effects of Voriconazole-Loaded Nano-Liposome on Fluconazole-Resistant Clinical Isolates of Candida albicans, Biological Activity and ERG11, CDR1, and CDR2 Gene Expression.
- Published in:
- Assay & Drug Development Technologies, 2021, v. 19, n. 7, p. 453, doi. 10.1089/adt.2020.1057
- By:
- Publication type:
- Article
Correction to: association of the matrix metalloproteinases (MMPs) family gene polymorphisms and the risk of coronavirus disease 2019 (COVID-19); implications of contribution for development of neurological symptoms in the COVID-19 patients.
- Published in:
- 2023
- By:
- Publication type:
- Correction Notice
MicroRNA-155 acts as a potential prognostic and diagnostic factor in patients with ankylosing spondylitis by modulating SOCS3.
- Published in:
- Molecular Biology Reports, 2023, v. 50, n. 1, p. 553, doi. 10.1007/s11033-022-08033-5
- By:
- Publication type:
- Article
Association of the matrix metalloproteinases (MMPs) family gene polymorphisms and the risk of coronavirus disease 2019 (COVID-19); implications of contribution for development of neurological symptoms in the COVID-19 patients.
- Published in:
- Molecular Biology Reports, 2023, v. 50, n. 1, p. 173, doi. 10.1007/s11033-022-07907-y
- By:
- Publication type:
- Article
Progression or suppression: Two sides of the innate lymphoid cells in cancer.
- Published in:
- Journal of Cellular Biochemistry, 2020, v. 121, n. 4, p. 2739, doi. 10.1002/jcb.29503
- By:
- Publication type:
- Article
Downregulation of miR‐146a promotes cell migration in Helicobacter pylori–negative gastric cancer.
- Published in:
- Journal of Cellular Biochemistry, 2019, v. 120, n. 6, p. 9495, doi. 10.1002/jcb.28225
- By:
- Publication type:
- Article
microRNA‐193a‐5p inhibits migration of human HT‐29 colon cancer cells via suppression of metastasis pathway.
- Published in:
- Journal of Cellular Biochemistry, 2019, v. 120, n. 5, p. 8775, doi. 10.1002/jcb.28164
- By:
- Publication type:
- Article
Potential of chimeric antigen receptor (CAR)‐redirected immune cells in breast cancer therapies: Recent advances.
- Published in:
- Journal of Cellular & Molecular Medicine, 2022, v. 26, n. 15, p. 4137, doi. 10.1111/jcmm.17465
- By:
- Publication type:
- Article
Up‐regulation of KISS1 as a novel target of Let‐7i in melanoma serves as a potential suppressor of migration and proliferation in vitro.
- Published in:
- Journal of Cellular & Molecular Medicine, 2021, v. 25, n. 14, p. 6864, doi. 10.1111/jcmm.16695
- By:
- Publication type:
- Article
New immunotherapy approaches for colorectal cancer: focusing on CAR-T cell, BiTE, and oncolytic viruses.
- Published in:
- Cell Communication & Signaling, 2024, v. 22, n. 1, p. 1, doi. 10.1186/s12964-023-01430-8
- By:
- Publication type:
- Article
A comprehensive review about the utilization of immune checkpoint inhibitors and combination therapy in hepatocellular carcinoma: an updated review.
- Published in:
- Cancer Cell International, 2022, v. 22, n. 1, p. 1, doi. 10.1186/s12935-022-02682-z
- By:
- Publication type:
- Article
A comprehensive review about the utilization of immune checkpoint inhibitors and combination therapy in hepatocellular carcinoma: an updated review.
- Published in:
- Cancer Cell International, 2022, v. 22, n. 1, p. 1, doi. 10.1186/s12935-022-02682-z
- By:
- Publication type:
- Article
Biological causes of immunogenic cancer cell death (ICD) and anti-tumor therapy; Combination of Oncolytic virus-based immunotherapy and CAR T-cell therapy for ICD induction.
- Published in:
- Cancer Cell International, 2022, v. 22, n. 1, p. 1, doi. 10.1186/s12935-022-02585-z
- By:
- Publication type:
- Article
The Role of Janus Kinase/STAT3 Pathway in Hematologic Malignancies With an Emphasis on Epigenetics.
- Published in:
- Frontiers in Genetics, 2021, v. 12, p. 1, doi. 10.3389/fgene.2021.703883
- By:
- Publication type:
- Article
PD‐1/PD‐L1 blockade: Prospectives for immunotherapy in cancer and autoimmunity.
- Published in:
- IUBMB Life, 2021, v. 73, n. 11, p. 1293, doi. 10.1002/iub.2558
- By:
- Publication type:
- Article
The lethal internal face of the coronaviruses: Kidney tropism of the SARS, MERS, and COVID19 viruses.
- Published in:
- IUBMB Life, 2021, v. 73, n. 8, p. 1005, doi. 10.1002/iub.2516
- By:
- Publication type:
- Article
miR‐143 acts as an inhibitor of migration and proliferation as well as an inducer of apoptosis in melanoma cancer cells in vitro.
- Published in:
- IUBMB Life, 2020, v. 72, n. 9, p. 2034, doi. 10.1002/iub.2345
- By:
- Publication type:
- Article
Dysregulation of Survivin-Targeting microRNAs in Autoimmune Diseases: New Perspectives for Novel Therapies.
- Published in:
- Frontiers in Immunology, 2022, v. 13, p. 1, doi. 10.3389/fimmu.2022.839945
- By:
- Publication type:
- Article
Correction: A comprehensive review about immune responses and exhaustion during coronavirus disease (COVID-19).
- Published in:
- 2022
- By:
- Publication type:
- Correction Notice
Immune system-related soluble mediators and COVID-19: basic mechanisms and clinical perspectives.
- Published in:
- Cell Communication & Signaling, 2022, v. 20, n. 1, p. 1, doi. 10.1186/s12964-022-00948-7
- By:
- Publication type:
- Article
Correction: Anastasis: cell recovery mechanisms and potential role in cancer.
- Published in:
- 2022
- By:
- Publication type:
- Correction Notice
Anastasis: cell recovery mechanisms and potential role in cancer.
- Published in:
- Cell Communication & Signaling, 2022, v. 20, n. 1, p. 1, doi. 10.1186/s12964-022-00880-w
- By:
- Publication type:
- Article
Anastasis: cell recovery mechanisms and potential role in cancer.
- Published in:
- Cell Communication & Signaling, 2022, v. 20, n. 1, p. 1, doi. 10.1186/s12964-022-00880-w
- By:
- Publication type:
- Article
Correction to: A comprehensive review about immune responses and exhaustion during coronavirus disease (COVID-19).
- Published in:
- 2022
- By:
- Publication type:
- Correction Notice
A comprehensive review about immune responses and exhaustion during coronavirus disease (COVID-19).
- Published in:
- Cell Communication & Signaling, 2022, v. 20, n. 1, p. 1, doi. 10.1186/s12964-022-00856-w
- By:
- Publication type:
- Article
A comprehensive review about immune responses and exhaustion during coronavirus disease (COVID-19).
- Published in:
- Cell Communication & Signaling, 2022, v. 20, n. 1, p. 1, doi. 10.1186/s12964-022-00856-w
- By:
- Publication type:
- Article
Tumor immunotherapies by immune checkpoint inhibitors (ICIs); the pros and cons.
- Published in:
- Cell Communication & Signaling, 2022, v. 20, n. 1, p. 1, doi. 10.1186/s12964-022-00854-y
- By:
- Publication type:
- Article
Cancer combination therapies by angiogenesis inhibitors; a comprehensive review.
- Published in:
- Cell Communication & Signaling, 2022, v. 20, n. 1, p. 1, doi. 10.1186/s12964-022-00838-y
- By:
- Publication type:
- Article
The role of immune regulatory molecules in rheumatoid arthritis: Implication for etiopathogenesis and prospective for treatment.
- Published in:
- Journal of Cellular Physiology, 2022, v. 237, n. 9, p. 3541, doi. 10.1002/jcp.30855
- By:
- Publication type:
- Article
Mesenchymal stem cells as carrier of the therapeutic agent in the gene therapy of blood disorders.
- Published in:
- Journal of Cellular Physiology, 2020, v. 235, n. 5, p. 4120, doi. 10.1002/jcp.29324
- By:
- Publication type:
- Article
A new insight into thymosin β4, a promising therapeutic approach for neurodegenerative disorders.
- Published in:
- Journal of Cellular Physiology, 2020, v. 235, n. 4, p. 3270, doi. 10.1002/jcp.29293
- By:
- Publication type:
- Article
MicroRNAs: Small molecules with a large impact on pre‐eclampsia.
- Published in:
- Journal of Cellular Physiology, 2020, v. 235, n. 4, p. 3235, doi. 10.1002/jcp.29286
- By:
- Publication type:
- Article
The effect of combined miR‐200c replacement and cisplatin on apoptosis induction and inhibition of gastric cancer cell line migration.
- Published in:
- Journal of Cellular Physiology, 2019, v. 234, n. 12, p. 22581, doi. 10.1002/jcp.28823
- By:
- Publication type:
- Article
Cover Image, Volume 233, Number 3, March 2018.
- Published in:
- 2019
- By:
- Publication type:
- Front Cover
MicroRNAs in cancer drug resistance: Basic evidence and clinical applications.
- Published in:
- Journal of Cellular Physiology, 2019, v. 234, n. 3, p. 2152, doi. 10.1002/jcp.26810
- By:
- Publication type:
- Article
CD133: An emerging prognostic factor and therapeutic target in colorectal cancer.
- Published in:
- Cell Biology International, 2020, v. 44, n. 2, p. 368, doi. 10.1002/cbin.11243
- By:
- Publication type:
- Article
A Deep Insight Into CAR-T Cell Therapy in Non-Hodgkin Lymphoma: Application, Opportunities, and Future Directions.
- Published in:
- Frontiers in Immunology, 2021, v. 12, p. 1, doi. 10.3389/fimmu.2021.681984
- By:
- Publication type:
- Article
Under hypoxic conditions, MSCs affect the expression and methylation level of survival‐related genes in ALL independent of apoptosis pathways in vitro.
- Published in:
- Biotechnology & Applied Biochemistry, 2022, v. 69, n. 2, p. 822, doi. 10.1002/bab.2154
- By:
- Publication type:
- Article
Cardiotoxicity of immune checkpoint inhibitors: An updated review.
- Published in:
- Biotechnology & Applied Biochemistry, 2022, v. 69, n. 1, p. 61, doi. 10.1002/bab.2081
- By:
- Publication type:
- Article
Harmful effects of high amounts of glucose on the immune system: An updated review.
- Published in:
- Biotechnology & Applied Biochemistry, 2021, v. 68, n. 2, p. 404, doi. 10.1002/bab.1938
- By:
- Publication type:
- Article
Effects of CD133 Silencing on Survival and Migration of HT-29 Colorectal Cancer Cells.
- Published in:
- Iranian Journal of Immunology, 2019, v. 16, n. 3, p. 246, doi. 10.22034/iji.2019.80275.
- By:
- Publication type:
- Article
Therapeutic utility of mesenchymal stromal cell (MSC)-based approaches in chronic neurodegeneration: a glimpse into underlying mechanisms, current status, and prospects.
- Published in:
- Cellular & Molecular Biology Letters, 2022, v. 27, n. 1, p. 1, doi. 10.1186/s11658-022-00359-z
- By:
- Publication type:
- Article
CRISPR/Cas9 application in cancer therapy: a pioneering genome editing tool.
- Published in:
- Cellular & Molecular Biology Letters, 2022, v. 27, n. 1, p. 1, doi. 10.1186/s11658-022-00336-6
- By:
- Publication type:
- Article
Emerging role of mesenchymal stromal cells (MSCs)-derived exosome in neurodegeneration-associated conditions: a groundbreaking cell-free approach.
- Published in:
- Stem Cell Research & Therapy, 2022, v. 13, n. 1, p. 1, doi. 10.1186/s13287-022-03122-5
- By:
- Publication type:
- Article
Hurdles to breakthrough in CAR T cell therapy of solid tumors.
- Published in:
- Stem Cell Research & Therapy, 2022, v. 13, n. 1, p. 1, doi. 10.1186/s13287-022-02819-x
- By:
- Publication type:
- Article
Human epidermal growth factor receptor 2 (HER2)-specific chimeric antigen receptor (CAR) for tumor immunotherapy; recent progress.
- Published in:
- Stem Cell Research & Therapy, 2022, v. 13, n. 1, p. 1, doi. 10.1186/s13287-022-02719-0
- By:
- Publication type:
- Article